The role of glutamate, calcium and magnesium in secondary brain injury

Journal of Veterinary Emergency and Critical Care

Volumn 12, Issue 1, 2002, Pages 17-32

  Leonard, Susan E ^a   Kirby, Rebecca ^b  

^a Animal Emergency Hospital   (United States)

^b Animal Emergency Center   (United States)

Author keywords

Elevated intracellular calcium; Excitatory amino acid; Glutamate; Nmda; Traumatic brain injury

Indexed keywords

EID: 13444273807     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1046/j.1534-6935.2002.00003.x     Document Type: Review

References (164)

1. Hayek DA & Veremakis C. Intracranial Pathophysiology of Brain Injury. In: Veremakis C, ed. Problems in Critical Care: Resuscitation Following Acute Brain Injury. Philadelphia: Lippincott 1991, pp. 135 – 155.
2. Prough DS & DeWitt DS. Cerebral Protection. In: Chernow, B, ed. The Pharmacologic Approach to the Critically Ill Patient. Philadelphia: Williams & Wilkins; 1994, pp. 247 – 271.
3. Chestnut RM. Secondary Brain Insults After Head Injury. Clinical Perspectives. New Horizons 1995; 3:366 – 375.pmid/7496744
4. Segatore M. Corticosteroids and Traumatic Brain Injury: Status at the End of the Decade of the Brain. J Neurosci Nursing 1999; 31:239 – 250.
5. Juurlink BH & Paterson PG. Review of Oxidative Stress in Brain and Spinal Cord Injury: Suggestions for Pharmacological and Nutritional Management Strategies. J Spinal Cord Med 1998; 21:309 – 334.pmid/10096045
6. Zink BJ. Traumatic brain injury. In: Emergency Medicine Clinics of North America – Critical Resuscitations. Philadelphia: WB. Saunders Co 1996, pp. 115 – 150.
7. Lee J, Grabb MC, Zipfel GJ, et al. Brain tissue responses to ischemia. J Clin Invest 2000; 106:723 – 731.pmid/10995780
8. Olney JW. Excitatory Transmitter Neurotoxicity. Neurobiol Aging 1994; 15:259 – 260.pmid/7838306
9. Choi DW. Ionic Dependence of Glutamate Neurotoxocity. J Neurosci 1987; 7:369 – 379.pmid/2880938
10. Choi DW. Excitotoxic Cell Death. J Neurobiol 1992; 23:1261 – 1276.pmid/1361523
11. Alessandri B & Bullock R. Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries. Prog Brain Res 1998; 116:303 – 330.pmid/9932385
12. Hasbani MJ, Hyrc KL, Faddis BT, et al. Distinct roles for sodium, chloride, and calcium in excitotoxic dendritic injury and recovery. Exp Neurol 1998; 154:241 – 258.pmid/9875285DOI: 10.1006/exnr.1998.6929
13. Kato H & Kanellopoulos GK. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Exper Neurol 1997; 148:464 – 474.
14. Johnson EM & Greenlund LJS. Neuronal apoptosis: Current understanding of molecular mechanisms and potential role in ischemic brain injury. J Neurotrauma 1995; 12:843 – 849.pmid/8594212
15. Maeno E, Ishizak Y, Kanaseki T, et al. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. PNAS 2000; 97:9487 – 9492.pmid/10900263
16. Yu SP & Choi DW. Ions, cell volume, and apoptosis. PNAS 2000; 97:9360 – 9362.pmid/10944207
17. Matsushita Y, Shima K, Nawashiro H, et al. Real-time monitoring of glutamate following fluid percussion brain injury with hypoxia in the rat. J Neurotrauma 2000,17: 143 – 153.
18. Martin LJ, Sieber FE & Traystman RJ. Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways. J Cereb Blood Flow Metab 2000; 20:153 – 167.pmid/10616804
19. Zipfel GJ, Babcock D, Lee J, et al. Neuronal apoptosis after CNS injury: The roles of glutamate and calcium. J Neurotrauma 2000; 17:857 – 869.pmid/11063053
20. Eldadah BA & Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 2000; 17:811 – 829.pmid/11063050
21. Bredesen DE. Apoptosis: Overview and signal transduction pathways. J Neurotrauma 2000; 17:801 – 810.pmid/11063049
22. Raghupathi R, Graham DI & McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000; 17:927 – 937.pmid/11063058
23. Sahuquillo J, Poca MA & Amoros S. Current aspects of pathophysiology and cell dysfunction after severe head injury. Curr Pharm Des 2001; 7:1475 – 1503.pmid/11562294
24. Monaghan DT, Bridges RJ & Cotman CW. The excitatory amino acid receptors. Annu Rev Pharmacol Toxicol 1989; 29:365 – 402.pmid/2543272
25. Albers GW, Goldberg MP & Choi DW. NMDA antagonists: Ready for clinical trial in brain ischemia? Ann Neurol 1989; 25:398 – 403.pmid/2565699
26. Massieu L, Morales-Villagran A & Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage. J Neurochem 1995; 64:2262 – 2272.pmid/7722511
27. Berl S, Lajtha A & Waelsch H. Amino acid and protein metabolism. J Neurochem 1961; 7:186 – 197.
28. Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984; 42:1 – 11.pmid/6139418
29. Hattori H & Wasterlain CG. Excitatory amino acids in the developing brain. Ontogeny, plasticity, and excitotoxicity. Pediatr Neurol 1990; 6(4): 219 – 228.pmid/2169749
30. Schousboe A. Transport and metabolism of glutamate and GABA in neurons and glial cells. Int Rev Neurobiol 1981; 22:1 – 16.pmid/6115823
31. Erecinska M & Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990; 35:245 – 296.pmid/1980745
32. Erecinska M, Zaleska MM & Nissim I. Glucose and synaptosomal glutamate metabolism. J Neurochem 1988; 51:892 – 900.pmid/2900879
33. Rhoades RA & Tanner GA. Medical Physiology. New York: Little, Brown & Company 1995, p. 51.
34. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623 – 634.pmid/2908446
35. Ganong W. Synaptic and Junctional Transmission. In: Review of Medical Physiology. Connecticut: Appleton & Lange 1989, pp. 74 – 102.
36. Brann DW. Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 1995; 61:213 – 225.pmid/7898626
37. Cunningham MD, Ferkany JW & Enna SJ. Excitatory amino acid receptors: A gallery of new targets for pharmacological intervention. Life Sci 1993; 54:135 – 148.
38. Barnes JM & Henley JM. Molecular characteristics of excitatory amino acid receptors. Prog Neurobiol 1992; 39:113 – 133.pmid/1354385
39. Baskys A. The metabotropic glutamate receptor concept. In: Metabotropic Glutamate Receptors. Austin, TX: RG Landes Company 1994, pp. 1 – 4.
40. Davies J, Evans RH, Francis AA, et al. Excitatory amino acid receptors in the vertebrate central nervous system. In: Littauer UZ, Dudai Y, eds. Neurotransmitters and Their Receptors. New York: John Wiley & Sons Ltd 1980, pp. 333 – 347.
41. Lipton SA. Calcium channel antagonists in the prevention of neurotoxicity. Adv Pharm 1991; 22:271 – 297.
42. Schoepp DD & Sacaan AI. Metabotropic glutamate receptors and neuronal degenerative disorders. Neurobiol Aging 1994; 15:261 – 263.pmid/7838307
43. Faden AI, Demediuk P, Panter SS & Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244:798 – 800.pmid/2567056
44. Razdan B, Kubin J, Mishra OP & Delivoria-Papadopoulos M. Modification of the glycine binding site of the NMDA receptor in the guinea pig fetus brain during development following hypoxia. Brain Res 1996; 733:15 – 20.pmid/8891243
45. Lipton SA & Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl J Med 1994; 330:613 – 622.pmid/7905600
46. Nowak L, Bregestovski P, Ascher P, et al. Magnesium gates glutamate activated channels in mouse central neurones. Nature 1984; 307:462 – 465.pmid/6320006
47. Baethmann A & Kempski O. Biochemical factors and mechanisms of secondary brain damage in cerebral ischemia and trauma. In: Bazan NG, ed. Neurochemical Correlates of Cerebral Ischemia. New York: Plenum Press 1992, pp. 295 – 320.
48. Boarder MR. Presynaptic aspects of cotransmission: Relationship between vesicles and neurotransmitters. J Neurochem 1989; 53:1 – 9.pmid/2566652
49. Zornow MH & Prough DS. Neuroprotective properties of calcium-channel blockers. New Horizons 1996; 4:107 – 114.pmid/8689265
50. Miller RJ. Calcium signalling in neurons. Trends Neuro Sci 1988; 11:415 – 419.
51. Guyton AC. Organization of the nervous system. In: Textbook of Medical Physiology. Philadelphia: W.B. Saunders Company 1991, pp. 478 – 494.
52. Blaustein MP. Calcium transport and buffering in neurons. Trends Neurosci 1988; 11:438 – 443.pmid/2469161
53. Sloviter RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neuro 1989; 280:183 – 196.
54. Bouchelouche P, Belhage B, Frandsen A, et al. Glutamate receptor activation in cultured cerebellar granule cells increases cytosolic free calcium by mobilization of cellular calcium and activation of calcium influx. Exp Brain Res 1989; 76:281 – 291.pmid/2569984
55. Nahorski SR. Inositol polyphosphates and neuronal calcium homeostasis. Trends in Neurosci 1988; 11:444 – 448.
56. Andrew PJ & Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999; 43:521 – 531.pmid/10690324
57. Budd SL & Nicholls DG. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem 1996; 67:2282 – 2291.pmid/8931459
58. Meldolesi J, Volpe P & Pozzan T. The intracellular distribution of calcium. Trends in Neurosci 1988; 11:449 – 452.
59. Peters T. Cellular movements and distribution of calcium. In: Hartmann A, Kuschinsky W, eds. Cerebral Ischemia and Calcium. Berlin: Springer-Verlag; 1989, pp. 30 – 36.
60. Volpe P, Krause KH, Hashimoto S, et al. “Calciosome”, a cytoplasmic organelles: The inositol 1,4,5-triphosphate-sensitive calcium store of nonmuscle cells? Proc Natl Acad Sci USA 1988; 85:1091 – 1095.pmid/3257572
61. Mayer ML, Westbrook GL & Guthrie PB. Voltage-dependent block by magnesium of NMDA responses in spinal cord neurones. Nature 1984; 309:261 – 263.pmid/6325946
62. Martin LG, Wingfield WE, Van Pelt DR, et al. Magnesium in the 1990s: Implications for veterinary critical care. Vet Emerg Crit Care 1993; 3:105 – 114.
63. Martin LG, Matteson VL, Wingfield WE, et al. Abnormalities of serum magnesium in critically ill dogs: Incidence and complications. Vet Emerg Crit Care 1994; 4:15 – 20.
64. Martin LG, Van Pelt DR & Wingfield WE. Magnesium and the critically ill patient. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XII. Philadelphia: WB Saunders Company; 1995, pp. 128 – 131.
65. Aikawa JK. Magnesium: Its Biologic Significance. Boca Raton: CRC Press; 1981, pp. 21 – 29.
66. McIntosh TK, Vink R, Yamakami I & Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res 1989; 482:252 – 260.pmid/2784989
67. Seelig JM, Wei EP, Kontos HA, et al. Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am J Physiol 1983; 245:H22 – H26.pmid/6869560
68. Goodman JC, Valadka AB, Gopinath SP, et al. Simultaneous measurement of cortical potassium, calcium, and magnesium levels measured in head injured patients using microdialysis with ion chromotography. Acta Neurochir 1999; 75:35 – 37.
69. Muir JK, Raghupathi R, Emery D, et al. Post-injury magnesium treatment attenuates traumatic brain injury-induced cortical induction of p53 mRNA in rats. Exp Neurol 1999; 159:584 – 593.pmid/10506531
70. 4 ) therapy in traumatic brain injury. J Neurotrauma 2000; 17:1041 – 1053.pmid/11101207
71. Van Landeghem FK, Stover JF, Bechmann I, et al. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 2001; 35:167 – 179.pmid/11494408DOI: 10.1002/glia.1082
72. McAdoo DJ, Xu G, Robak G, et al. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord. Brain Res 2000; 865:283 – 285.pmid/10821933
73. Torp R & Lekieffre D. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp Brain Res 1995; 103:51 – 58.pmid/7615037
74. Rao VL & Baskaya MK. Traumatic brain injury down regulates glial glutamate transporter (GLT1 and GLAST) proteins in the rat brain. J Neurochem 1998; 70:2020 – 2027.pmid/9572288
75. Farooque M, Hillered L, Holtz A, et al. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: An experimental study in the rat using microdialysis. J Neurotrauma 1996; 13:537 – 548.pmid/8913970
76. Kimelberg HK, Goderie SK, Higman S, et al. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 1990; 10:1583 – 1591.
77. Baethmann A, Maier-Hauff K, Schurer L, et al. Release of glutamate and of free fatty acids in vasogenic brain edema. J Neurosurg 1989; 70:578 – 591.pmid/2564431
78. Graham SH, Shiraishi K, Panter S, et al. Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci Lett 1990; 110:124 – 130.pmid/1970140
79. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164:719 – 721.pmid/5778021
80. Drejer J, Benveniste H, Diemer NH, et al. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 1985; 45:145 – 151.pmid/2860206
81. Benveniste H, Drejer J, Schousboe A, et al. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43:1369 – 1374.pmid/6149259
82. Baker AJ, Zornow MH, Scheller MS, et al. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J Neurochem 1991; 57:1370 – 1379.pmid/1895110
83. Goodman JC, Valadka AB, Gopinath SP, et al. Lactate and excitatory amino acids measured by microdialysis are decreased by pentobarbital coma in head-injured patients. J Neurotrauma 1996; 13:549 – 556.pmid/8915906
84. Yamamoto T, Rossi S, Stiefel M, et al. CSF and ECF glutamate concentrations in head injured patients. Acta Neurochir 1999; 75:17 – 19.
85. Koura SS, Doppenberg EMR, Marmarou A, et al. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir 1998; 71:244 – 246.
86. Gopinath SP, Valadka AB, Goodman JC, et al. Extracellular glutamate and aspartate in head injured patients. Acta Neurochir Suppl 2000; 76:437 – 438.pmid/11450062
87. Hong Z, Xinding Z, Tianlin Z, et al. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clin Chem 2001; 47:1458 – 1462.pmid/11468237
88. Bullock R, Zauner A, Woodward JJ, et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 1998; 89:507 – 518.pmid/9761042
89. Bullock R, Zauner A, Myseros JS, et al. Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann NY Acad Sci 1995; 765:290 – 297.pmid/7486616
90. Alessandri B, Doppenberg E, Bullock R, et al. Glucose and lactate metabolism after severe human head injury: Influence of excitatory neurotransmitters and injury type. Acta Neurochir 1999; 75:21 – 24.
91. Suh SW, Chen JW, Motamedi M, et al. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 2000; 852:268 – 273.pmid/10678752
92. Choi DW & Koh JY. Zinc and brain injury. Ann Rev Neurosci 1998; 21:347 – 375.pmid/9530500
93. Colvin RA, Davis N, Nipper RW, et al. Zinc transport in the brain: Routes of zinc influx and efflux in neurons. J Nutr 2000; 130:1484 – 1487.
94. Frederickson CJ, Suh SW, Silva D, et al. Importance of zinc in the central nervous system: the zinc containing neuron. J Nutr 2000; 130:1471 – 1483.
95. Trump BF & Berezesky IK. Calcium-mediated cell injury and cell death. New Horizons 1996; 4:139 – 150.pmid/8689270
96. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends in Neurosci 1988; 11:465 – 469.
97. Fiskum G. Mitochondrial participation in ischemia and traumatic neural cell death. J Neurotrauma 2000; 17:843 – 855.pmid/11063052
98. Ferger D & Krieglstein J. Determination of intracellular calcium concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs. Brain Res 1996; 732:87 – 94.pmid/8891272
99. Braughler JM & Hall ED. Central nervous system trauma and stroke: Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6:289 – 301.pmid/2663662
100. Samdani AF, Dawson TM & Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 1997; 28:1283 – 1288.pmid/9183363
101. Johnston MV, Trescher WH, Ishida A, et al. Novel treatments after experimental brain injury. Semin Neonatol 2000; 5:75 – 86.pmid/10802752
102. Raghavendra Rao VL, Dogan A, Bowen KK, et al. Traumatic injury to rat brain upregulates neuronal nitric oxide synthase expression and L-[H]nitroarginine binding. J Neurotrauma 1999; 16:865 – 877.pmid/10547096
103. DeWitt DS, Jenkins LW, Prough DS. Enhanced vulnerability to secondary ischemic insults after experimental traumatic brain injury. New Horizons 1995; 3:376 – 383.pmid/7496745
104. Vink R & McIntosh T, et al. Decrease in total and free magnesium concentration following traumatic brain injury in rats. Biochem Biophys Res Comm 1987; 149:594 – 599.pmid/3426591
105. Vink R & McIntosh T. Decline in intracellular free magnesium is associated with irreversible tissue injury after brain trauma. J Biol Chem 1988; 263:757 – 761.pmid/3335524
106. Heath DL & Vink R. Traumatic brain axonal injury produces sustained decline in intracellular free magnesium concentration. Brain Res 1996; 738:150 – 153.pmid/8949939
107. Vink R, Heath DL & McIntosh TK. Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. J Neurochem 1996; 66:2477 – 2483.pmid/8632172
108. Heath DL & Vink R. Blood-free magnesium concentration declines following graded experimental traumatic brain injury. Scand J Clin Laboratory Invest 1998; 58:161 – 166.
109. Heath DL & Vink R. Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration. J Neurotrauma 2001; 18:465 – 469.pmid/11336446
110. McIntosh T & Vink R. Magnesium protects against neurological deficit after brain injury. Brain Res 1989; 482:252 – 260.pmid/2784989
111. Heath DL & Vink R. Brain free magnesium concentration is predictive of motor outcome following traumatic axonal brain injury in rats. Magnes Res 1999; 12:269 – 277.pmid/10612084
112. Emerson CS & Vink R. Increased mortality in female rats after brain trauma is associated with lower free magnesium. Neuro Report 1992; 3:957 – 960.
113. Kahlke V, Angele MK, Ayal A, et al. Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine 2000; 12:69 – 77.pmid/10623445
114. Diodato MD, Knoferl MW, Schwacha MG, et al. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001; 14:162 – 169.pmid/11396994
115. Vink R. Phospholipase C activity reduces free magnesium concentration. Biochem Biophys Res Comm 1989; 165:913 – 918.pmid/2597165
116. Vink R. Magnesium and brain trauma. Magnes Trace Elem 199192; 10:1 – 10.pmid/1814317
117. Bareyre FM, Saatman KE, Raghupathi R, et al. Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats. J Neurotrauma 2000; 17:1029 – 1039.pmid/11101206
118. Bareyre FM, Saatman KE, Helfaer MA, et al. Alterations in ionized and total blood magnesium after experimental traumatic brain injury: relationship to neurobehavioral outcome and neuroprotective efficacy of magnesium chloride. J Neurochem 1999; 73:271 – 280.pmid/10386980
119. Marshall LF & Marshall SB. Pharmacologic therapy: Promising clinical investigations. New Horizons 1995; 3:573 – 580.pmid/7496769
120. Chestnut RM. Medical management of severe head injury: Present and future. New Horizons 1995; 3:581 – 593.pmid/7496770
121. Clausen T & Bullock R. Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 2001; 15:1517 – 1532.
122. Whitelaw A. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin Neonatal 2000; 5:33 – 40.
123. Matsushita Y, Bramlett HM, Alonso O, et al. Posttraumatic hypothermia is neuroprotective in a model of traumatic brain injury complicated by a secondary hypoxic insult. Crit Care Med 2001; 29:2060 – 2066.pmid/11700395
124. Bramlett HM, Green EJ, Dietrich WD, et al. Posttraumatic brain hypothermia provides protection from sensorimotor and cognitive behavioral deficits. J Neurotrauma 1995; 12:289 – 298.pmid/7473803
125. Dietrich WD, Alonso O, Busto R, et al. Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol 1994; 87:250 – 258.pmid/8009957
126. Ginsberg MD, Globus MY, Dietrich WD, et al. Temperature modulation of ischemic brain injury – a synthesis of recent advances. Prog Brain Res 1993; 96:13 – 22.pmid/8101386
127. Huh PW, Belayev L, Zhao W, et al. Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischmeic hypothermia in focal cerebral ischemia. J Neurosurg 2000; 92:91 – 99.pmid/10616087
128. Thoresen M. Cooling the newborn after asphyxia – physiological and experimental background and its clinical use. Semin Neonatol 2000; 5:61 – 73.pmid/10802751
129. Marion DW. Therapeutic moderate hypothermia and fever. Curr Pharm Des 2001; 7:1533 – 1536.pmid/11562297
130. Suehiro E, Fujisawa H, Ito H, et al. Brain temperture modifies glutamate neurotoxicity in vivo. J Neurotrauma 1999; 16:285 – 297.pmid/10225215
131. Takagi K, Ginsberg MD, Globus MY, et al. Effect of hyperthermia on glutamate release in ischemic penumbra after middle cerebral artery occlusion in rats. Am J Physiol 1994; 267:1770 – 1776.
132. Globus MY, Alonso O, Dietrich WD, et al. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem 1995; 65:1704 – 1711.pmid/7561868
133. Maeda T, Katayama Y, Kawamata T, et al. Mechanisms of excitatory amino acid release in contused brain tissue: effects of hypothermia and in situ administration of Co2+ on extracellular levels of glutamate. J Neurotrauma 1998; 15:655 – 664.pmid/9753213
134. Smith DH, Casey K & McIntosh TK. Pharmacologic therapy for traumatic brain injury – experimental approaches. New Horizons 1995; 3:562 – 572.
135. Laurer HL & McIntosh TK. Pharmacologic therapy in traumatic brain injury: Update on experimental treatment strategies. Curr Pharm Des 2001; 7:1505 – 1516.pmid/11562295
136. Steen PA, Newberg LA, Milde JH, et al. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1984; 4:82 – 87.pmid/6693515
137. Uematsu D, Greenberg JH, Hickey WF, et al. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 1989; 20:1531 – 1537.pmid/2815188
138. Tateishi A & Fleischer JE, et al. Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats. Stroke 1989; 20:1044 – 1050.pmid/2756536
139. Kumar K, Krause G, Koetner A, et al. Effect of flunarazine on global ischemia in the dog: a quantitative morphologic assessment. Exper Neurol 1987; 97:115 – 127.
140. Langham J, Goldfrad C, Teasdale G, et al. Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev 2000. julia.langham@ha.kcw-ha.nthames.nhs.uk.
141. Chen M, Bullock R; Graham DI, et al. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. In: Chew M, ed. NMDA Antagonists and Stroke. Ann Neurol 1991; 30:62 – 70.
142. Tsuchida E & Bullock R. The effect of the glycine site-specific NMDA antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 1995; 12:279 – 287.pmid/7473802
143. Tsuchida E & Rice M. The neuroprotective effect of the forebrain selective NMDA antagonist CP101,606 upon focal ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 1997; 14:409 – 415.pmid/9219855
144. Wasterlain CG, Adams LM, Hattori H, et al. Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J Pharmacol 1992; 212:275 – 278.pmid/1601070
145. Takano K, Tatlisumak T, Formato JE, et al. Glycine site antagonist attenuates infarct size in experimental focal ischemia. Stroke 1997; 28:1255 – 1263.pmid/9183359
146. Manchester KS, Jensen FE, Warach S, et al. Chronic administration of nitroglycerin decreases cerebral infarct size. Neurology 1993; 43:A365.
147. Carpenter CL, Marks SS, Watson DL, et al. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 1988; 439:372 – 375.pmid/2451974
148. Choi DW. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res 1987; 403: 333 – 336.pmid/2881608
149. Hirbee H, Gaviria M & Vignon J. Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor. CNS Drug Rev 2001; 7:172 – 198.pmid/11474423
150. Heath DL & Vink R. Magnesium sulphate improves neurologic outcome following severe closed head injury in rats. Neurosci Lett 1997; 228:175 – 178.pmid/9218636
151. 2 in closed head injury: a comparative phosphorus NMR study. J Neurotrauma 1998; 15:183 – 189.pmid/9528918
152. Heath DL & Vink R. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther 1999; 288:1311 – 1316.pmid/10027872
153. Heath DL & Vink R. Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. J Neurosurg 1999; 90:504 – 509.pmid/10067920
154. Hoane MR, Irish SL & Marks BB. Preoperative regimens of magnesium facilitate recovery of function and prevent subcortical atrophy following lesions of the rat sensorimotor cortex. Brain Res Bull 1998; 45:45 – 51.pmid/9434201
155. Guluma KZ, Saatman KE, Brown A, et al. Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone. J Neurotrauma 1999; 16:311 – 321.pmid/10225217
156. Frandsen A & Schousboe A. Dantrolene prevents glutamate cytotoxicity and calcium release from intracellular stores in cultured cerebral cortical neurons. J Neurochem 1991; 56:1075 – 1078.pmid/1671584
157. Lewen A, Matz P & Chan PH. Free radical pathways in CNS Injury. J Neurotrauma 2000; 17:871 – 890.pmid/11063054
158. Alderson P & Roberts I. Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. Br Med J 1997; 314:1855 – 1859.
159. Wahl F, Grosjean-Piot O, Bareyre F, et al. Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats. J Neurotrauma 2000; 17:1055 – 1061.pmid/11101208
160. Faden AI, Jacobs TP, et al. Endorphins in experimental spinal injury – Therapeutic effect of naloxone. Ann Neurol 1981; 10:326 – 332.
161. Zipfel GJ, Lee J & Choi DW. Reducing calcium overload in the ischemic brain. New Engl J Med 1999; 341:1543 – 1544.pmid/10559458
162. Graham DI, McIntosh TK, Maxwell WL, et al. Recent advances in neurotrauma. J Neuropath Exper Neurol 2000; 59:641 – 651.
163. Fedele E & Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol 1999; 58:89 – 120.pmid/10321798
164. Strijbos PJ, Leach MJ & Garthwaite J. Vicious cycle involving sodium channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J Neurosci 1996; 16:5004 – 5013.pmid/8756431